Q1 EPS Estimate for Pliant Therapeutics Boosted by Analyst
Pliant Therapeutics, Inc. (NASDAQ:PLRX – Free Report) – Leerink Partnrs upped their Q1 2025 earnings estimates for Pliant Therapeutics in a research report issued to clients and investors on Monday, March 3rd. Leerink Partnrs analyst F. Khurshid now expects that the company will post earnings of ($1.00) per share for the quarter, up from their […]
Pliant Therapeutics, Inc. (NASDAQ:PLRX – Free Report) – Leerink Partnrs upped their Q1 2025 earnings estimates for Pliant Therapeutics in a research report issued to clients and investors on Monday, March 3rd. Leerink Partnrs analyst F. Khurshid now expects that the company will post earnings of ($1.00) per share for the quarter, up from their […]
